We therefore suggest that, as an index coupling ER expression and glucose metabolism, the 18F-FDG/18F-FES SUV ratio might be a useful indicator of the relationship between sex hormone receptor status and cell proliferation in uterine tumors, especially in uterine sarcoma. The gene discussed is ESR1; the disease is uterine corpus sarcoma.